Cabot (CBT) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month target prices for Cabot's stock. Their CBT share price forecasts range from $80.00 to $113.00. On average, they anticipate the company's stock price to reach $91.75 in the next year. This suggests a possible upside of 23.7% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $66.84 at the beginning of 2023. Since then, CBT shares have increased by 11.0% and is now trading at $74.19.
View the best growth stocks for 2023 here.

Cabot saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 967,400 shares, an increase of 10.5% from the April 30th total of 875,500 shares. Based on an average daily volume of 286,100 shares, the days-to-cover ratio is presently 3.4 days. Currently, 1.8% of the shares of the company are short sold.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) announced its quarterly earnings results on Monday, May, 8th. The specialty chemicals company reported $1.33 EPS for the quarter, meeting analysts' consensus estimates of $1.33. The specialty chemicals company earned $1.03 billion during the quarter, compared to analyst estimates of $1.11 billion. Cabot had a net margin of 7.51% and a trailing twelve-month return on equity of 28.94%. The firm's revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.69 EPS.

Cabot declared a quarterly dividend on Friday, May 5th. Shareholders of record on Friday, May 26th will be given a dividend of $0.40 per share on Friday, June 9th. This represents a $1.60 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date is Thursday, May 25th. This is a positive change from the stock's previous quarterly dividend of $0.37.
Read our dividend analysis for CBT.

ETFs with the largest weight of Cabot (NYSE:CBT) stock in their portfolio include ProShares Smart Materials ETF (TINT), ProShares Nanotechnology ETF (TINY), Invesco DWA Basic Materials Momentum ETF (PYZ), Global X Autonomous & Electric Vehicles ETF (DRIV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Invesco S&P MidCap Momentum ETF (XMMO), Fidelity Women's Leadership ETF (FDWM) and First Trust Mid Cap Growth AlphaDEX Fund (FNY).

Cabot (NYSE:CBT) pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.17%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 28.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 25.24% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot updated its FY23 earnings guidance on Monday, May, 8th. The company provided EPS guidance of $6.10-$6.50 for the period, compared to the consensus earnings per share estimate of $6.45.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.64%), FMR LLC (8.34%), Wellington Management Group LLP (8.22%), State Street Corp (3.40%), Snyder Capital Management L P (3.13%) and Bank of America Corp DE (2.53%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $74.19.

Cabot (NYSE:CBT) has a market capitalization of $4.17 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $5.55 on an earnings per share basis.

The company employs 4,200 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.